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Background: There is conflicting data on impact of obesity on long- term cardiovascular outcomes in patients presenting with acute ST elevation 
myocardial infarction.
methods: We conducted a retrospective analysis of all patients undergoing percutaneous coronary intervention (PCI) at our center from January 
2003 through May 2010. We collected demographic, clinical and procedural characteristics on these patients. The patients were divided into two 
groups based on their Body Mass Index (BMI); group 1 consisted of non- obese patients with BMI < 30 and group 2 consisted of obese patients with 
BMI ≥ 30. The primary endpoint was major adverse cardiac events (MACE), which was a composite of annual incidence of hard clinical endpoints 
including all cause mortality, recurrent acute coronary syndrome (RACS) and cerebrovascular accident (CVA)/ transient ischemic attack (TIA). 
Secondary endpoints were annual incidence all cause mortality, RACS, CVA/ TIA, repeat revascularization and in-hospital major bleeding.
results: A total of 410 patients qualified for the study (259 non-obese and 151 obese patients). The incidence of traditional risk factors such 
as hypertension and diabetes mellitus was more common in obese patients, smoking was more common in the non-obese patients, however left 
ventricular ejection fraction was similar in both the groups. The primary endpoint occurred in 17% of non-obese patients and 14.6 % in obese 
patients (p=0.58). Among the secondary endpoints, the annual incidence of all cause mortality was 3.5 % in group 1 and 2.6% in group 2 (p= 
0.77); CVA/TIA was 1.2 % in group 1 and 0.7 % in group 2 (p= 1.0), RACS was 13.1 % in group 1 and 13.9 % in the group 2 (p = 0.88), repeat 
revascularization was 12.4 % in group 1 and 13.2 % in group 2 (0.88) and in-hospital major bleeding was 2.3 % in group 1 and 1.3 % in group 2 
(p=0.72).
conclusion: There is no difference in MACE or all cause mortality between obese and non- obese patients presenting with STEMI at one year.
